1. Home
  2. ASST vs WGS Comparison

ASST vs WGS Comparison

Compare ASST & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ASST

Asset Entities Inc. Class B

HOLD

Current Price

$12.39

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$65.62

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASST
WGS
Founded
2020
2017
Country
United States
United States
Employees
N/A
1300
Industry
Computer Software: Prepackaged Software
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
ASST
WGS
Price
$12.39
$65.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$23.50
$120.71
AVG Volume (30 Days)
4.9M
1.0M
Earning Date
05-14-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
82.56
N/A
EPS
N/A
N/A
Revenue
$633,489.00
N/A
Revenue This Year
$294.91
$29.98
Revenue Next Year
$12.16
$25.92
P/E Ratio
N/A
$1,251.58
Revenue Growth
128.67
N/A
52 Week Low
$0.49
$32.21
52 Week High
$19.75
$170.87

Technical Indicators

Market Signals
Indicator
ASST
WGS
Relative Strength Index (RSI) 41.73 55.31
Support Level $10.53 $55.76
Resistance Level $17.73 $73.46
Average True Range (ATR) 1.12 4.39
MACD -0.02 0.02
Stochastic Oscillator 32.13 56.54

Price Performance

Historical Comparison
ASST
WGS

About ASST Asset Entities Inc. Class B

Strive Inc is a structured finance company and institutional asset manager focused on disciplined capital allocation and long term value creation. The company has adopted bitcoin as its hurdle rate for capital deployment because of its fiduciary duty to maximize long-term value for stockholders, and compounding purchasing power over time. It operates in two reportable operating segments: the Asset Management segment, which provides investment advisory services and the Corporate & Other segment, which includes the company's bitcoin treasury operations. The majority of the revenue is derived from the Asset Management segment.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: